A study identified ARID1A as a key regulator of stomach cell recovery, showing that failed healing can create conditions that ...
Morning Overview on MSN
The first cellular age-reversal therapy has been cleared for human trials
Life Biosciences has received FDA clearance to begin a first-in-human Phase 1 clinical trial of ER-100, a gene therapy ...
Galderma (SWX:GALD) has unveiled results from the world’s most extensive skin quality profiling survey, finding that skin quality concerns are widespread, can impact emotional wellbeing and, while ...
Researchers at the University of Bayreuth and Forschungszentrum Jülich have demonstrated that specific light-sensitive ...
In a study published in Science Translational Medicine, a team of researchers led by Dr. Wang Yu from the Shenzhen Institutes ...
Candel Therapeutics (CADL) shifts to late-stage oncology with CAN-2409 Phase III wins and BLA catalyst. Read here for a ...
An international research team co-led by the Institute of Biomedicine and Biotechnology of Cantabria (IBBTEC-CSIC-University ...
Ionis Pharmaceuticals, Inc. today announced that it has completed enrollment in the pivotal cohort (Cohort 1) of the global Phase 3 REVEAL study evaluating obudanersen (ION582), an investigational RNA ...
Purpose The Guangxi Eco-Environmental Health and Aging Study (GEHAS) was established to investigate the interplay between eco ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results